TG Therapeutics: Share Price Slip On Q1 Earnings Unsurprising Given Challenges (TGTX)
This article was written byFollowEdmund Ingham is a biotech consultant. He has been covering biotech, healthcare, and pharma for over 5 years, and has put together detailed reports of over 1,000 companies. He leads the investing group Haggerston BioHealth. The...